Evidence map›Paper›PMID 41917362›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Microfluidic Shear-Based Assay for Assessing ADAMTS13 Activity Under Flow.

Noritaka Yada

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Noritaka YadaDepartment of General Medicine, Nara Medical University, Kashihara, Nara, Japan. n-yada@naramed-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A microfluidic system using the flow chamber techniques has long been utilized for thrombosis research. With the advent of technology, it has become possible to evaluate the relationship between blood flow dynamics and thrombus formation with greater precision. ADAMTS13, a plasma metalloprotease, efficiently cleaves von Willebrand factor (VWF) under flow conditions. The microfluidic shear-based assay is highly relevant for investigating the biological function of ADAMTS13. In this chapter, I describe the method using a microfluidic system to investigate the interaction between platelets and VWF, which is regulated by ADAMTS13. Whole blood samples obtained from mice with various genotypes, including wild type (WT), Adamts13-deficient (Adamts13

Indexed as

ADAMTS13 ProteinMicrofluidic Analytical TechniquesMicrofluidicsAnimalsBlood PlateletsHumansMiceNeutrophilsPurpura, Thrombotic Thrombocytopenicvon Willebrand FactorADAMTS13 ProteinADAMTS13 protein, humanvon Willebrand FactorADAMTS13MicrofluidicsNeutrophil extracellular trapsPlateletsThrombotic thrombocytopenic purpuravon Willebrand factor

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.